Pharma Access Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 25-07-2024
- Paid Up Capital ₹ 0.10 M
as on 25-07-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 198.07 Cr
as on 25-07-2024
- Revenue -20.20%
(FY 2023)
- Profit -51.43%
(FY 2023)
- Ebitda -210.76%
(FY 2023)
- Net Worth 8.23%
(FY 2023)
- Total Assets 13.88%
(FY 2023)
About Pharma Access
The Company is engaged in the Engineering Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹198.07 Cr.
Nilofer Parvaz and Shams Parvaz serve as directors at the Company.
- CIN/LLPIN
U74120MH2013PTC246924
- Company No.
246924
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Pharma Access Private Limited offer?
Pharma Access Private Limited offers a wide range of products and services, including Commissioning Services, Designing Services, Engineering Solution, ERP Solutions, Sales Support Services, After Sales Service, Data Digitization, Documentation Service.
Who are the key members and board of directors at Pharma Access?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilofer Parvaz  | Director | 13-Aug-2013 | Current |
| Shams Parvaz | Director | 13-Aug-2013 | Current |
Financial Performance and Corporate Structure Insights of Pharma Access.
Pharma Access Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.2% decrease. The company also saw a substantial fall in profitability, with a 51.43% decrease in profit. The company's net worth moved up by a moderate rise of 8.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharma Access?
In 2023, Pharma Access had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
A2v Insurance Brokers Private LimitedActive 5 years 3 monthsNilofer Parvaz and Shams Parvaz are mutual person
Technovation Healthcare Private LimitedActive 13 years 4 monthsNilofer Parvaz and Shams Parvaz are mutual person
- Modular Mobile Facility Private LimitedActive 4 years 1 month
Nilofer Parvaz and Shams Parvaz are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 May 2022 | ₹70.74 Cr | Open |
Others Creation Date: 08 Nov 2021 | ₹70.74 Cr | Open |
Others Creation Date: 28 Jun 2019 | ₹56.60 Cr | Open |
How Many Employees Work at Pharma Access?
Pharma Access has a workforce of 135 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharma Access, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharma Access's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
